Lucas E. Flausino

465 total citations · 1 hit paper
5 papers, 133 citations indexed

About

Lucas E. Flausino is a scholar working on Oncology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, Lucas E. Flausino has authored 5 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Immunology and 2 papers in Psychiatry and Mental health. Recurrent topics in Lucas E. Flausino's work include Cancer, Stress, Anesthesia, and Immune Response (2 papers), Inflammatory mediators and NSAID effects (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). Lucas E. Flausino is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (2 papers), Inflammatory mediators and NSAID effects (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). Lucas E. Flausino collaborates with scholars based in United States, Brazil and Myanmar. Lucas E. Flausino's co-authors include Hong‐Gyun Lee, Joon-Hyuk Lee, Francisco J. Quintana, Roger Chammas, Rajesh Balkrishnan, Fabian Camacho, Tatiane Katsue Furuya, Wen‐Jan Tuan and Maria Del Pilar Estevez-Diz and has published in prestigious journals such as Science Translational Medicine, BMC Cancer and Frontiers in Oncology.

In The Last Decade

Lucas E. Flausino

5 papers receiving 132 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neuroinflammation: An astrocyte perspective

2023 105 citations Hong‐Gyun Lee, Joon-Hyuk Lee et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Lucas E. Flausino

Since Specialization

Citations

This map shows the geographic impact of Lucas E. Flausino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas E. Flausino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas E. Flausino more than expected).

Fields of papers citing papers by Lucas E. Flausino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas E. Flausino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas E. Flausino. The network helps show where Lucas E. Flausino may publish in the future.

Co-authorship network of co-authors of Lucas E. Flausino

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas E. Flausino. A scholar is included among the top collaborators of Lucas E. Flausino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas E. Flausino. Lucas E. Flausino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Impact of SGLT2 inhibitors on survival in gastrointestinal cancer patients undergoing chemotherapy and/or radiotherapy: a real-world data retrospective cohort study 2025 ·BMC Cancer ·Lucas E. Flausino, (unknown), Tatiane Katsue Furuya, Wen‐Jan Tuan, Roger Chammas	4
2	Association of COX-inhibitors with cancer patients’ survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis 2024 ·Frontiers in Oncology ·Lucas E. Flausino, (unknown), Wen‐Jan Tuan, Maria Del Pilar Estevez-Diz, Roger Chammas	2
3	Neuroinflammation: An astrocyte perspective breakdown → 2023 ·Science Translational Medicine ·Hong‐Gyun Lee, Joon-Hyuk Lee, Lucas E. Flausino, Francisco J. Quintana	105
4	Effectiveness of immunological agents in non‐small cell lung cancer 2022 ·Cancer Reports ·(unknown), Lucas E. Flausino, (unknown), Rajesh Balkrishnan	8
5	Associations between initiating antihypertensive regimens on stage I–III colorectal cancer outcomes: A Medicare SEER cohort analysis 2021 ·Cancer Medicine ·Rajesh Balkrishnan, (unknown), (unknown), Fabian Camacho, Lucas E. Flausino, Roger Chammas	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact